Mark Altmeyer

Pres&Chief Commercial Officer, Sio Gene Therapies Inc.

Companies

Alector (United States)Board member Mar 21, 2024 to now¹
Myovant Sciences Ltd.Board member Oct 26, 2016 to Sep 4, 2018²
Sio Gene Therapies Inc.Pres&Chief Commercial Officer Jun 10, 2015 to Mar 16, 2018³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAlector (United States), Board member
2
SEC EDGARMyovant Sciences Ltd., Board member
3
SEC EDGARSio Gene Therapies Inc., Pres&Chief Commercial Officer